Arginine-vasopressin directly promotes a thermogenic and pro-inflammatory adipokine expression profile in brown adipocytes

Regulatory Peptides

Volumn 164, Issue 2-3, 2010, Pages 126-132

  Küchler, Sebastian ^a   Perwitz, Nina ^b   Schick, Rafael Reinhold ^a   Klein, Johannes ^b   Westphal, Sören ^a  

^a BUNDESWEHRKRANKENHAUS ULM   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Adipose function; Hypothalamic pituitary adrenal axis (HPA); Insulin resistance; Stress; UCP 1

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADIPOCYTOKINE; ARGIPRESSIN; GLUCOSE; INSULIN; LIPID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPEPTIDE; UNCOUPLING PROTEIN 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOCRINE FUNCTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT; INTRACELLULAR SPACE; LIPID STORAGE; METABOLIC REGULATION; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; THERMOGENESIS;

ADIPOCYTES, BROWN; ADIPOKINES; ADIPONECTIN; ANIMALS; ARGININE VASOPRESSIN; CELLS, CULTURED; CHEMOKINE CCL2; ENZYME INHIBITORS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMIDAZOLES; IMMUNOBLOTTING; INSULIN; INTERLEUKIN-6; ION CHANNELS; MICE; MITOCHONDRIAL PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PITUITARY-ADRENAL SYSTEM; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77955842837     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.05.016     Document Type: Article

References (48)

1. Zelena D., Domokos A., Jain S., Jankord R., Filaretova L. The stimuli-specific role of vasopressin in the hypothalamo-pituitary-adrenal axis response to stress. J Endocrinol 2009, 202(2):263-278.
2. Iwen K.A., Senyaman O., Schwartz A., Drenckhan M., Meier B., Hadaschik D., Klein J. Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes. J Endocrinol 2008, 196:465-472.
3. Stassen F.L., Heckman G., Schmidt D., Aiyar N., Nambi P., Crooke S.T. Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line. Mol Pharmacol 1987, 31:259-266.
4. Nemenoff R.A. Vasopressin signaling pathways in vascular smooth muscle. Front Biosci 1998, 3:d194-d207.
5. Chandrashekhar Y., Prahash A.J., Sen S., Gupta S., Roy S., Anand I.S. The role of arginine vasopressin and its receptors in the normal and failing rat heart. J Mol Cell Cardiol 2003, 35:495-504.
6. Ostrowski N.L., Young W.S., Knepper M.A., Lolait S.J. Expression of vasopressin V1a and V2 receptor messenger ribonucleic acid in the liver and kidney of embryonic, developing, and adult rats. Endocrinology 1993, 133:1849-1859.
7. Launay J.M., Vittet D., Vidaud M., Rondot A., Mathieu M.N., Lalau-Keraly C., Cantau B., Chevillard C. V1a-vasopressin specific receptors on human platelets: potentiation by ADP and epinephrine and evidence for homologous down-regulation. Thromb Res 1987, 45:323-331.
8. Hiroyama M., Aoyagi T., Fujiwara Y., Birumachi J., Shigematsu Y., Kiwaki K., Tasaki R., Endo F., Tanoue A. Hypermetabolism of fat in V1a vasopressin receptor knockout mice. Mol Endocrinol 2007, 21:247-258.
9. Aoyagi T., Izumi Y., Hiroyama M., Matsuzaki T., Yasuoka Y., Sanbe A., Miyazaki H., Fujiwara Y., Nakayama Y., Kohda Y., Yamauchi J., Inoue T., Kawahara K., Saito H., Tomita K., Nonoguchi H., Tanoue A. Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells. Am J Physiol Ren Physiol 2008, 295:F100-F107.
10. Fujiwara Y., Hiroyama M., Sanbe A., Aoyagi T., Birumachi J., Yamauchi J., Tsujimoto G., Tanoue A. Insulin hypersensitivity in mice lacking the V1b vasopressin receptor. J Physiol 2007, 584:235-244.
11. Nakamura K., Aoyagi T., Hiroyama M., Kusakawa S., Mizutani R., Sanbe A., Yamauchi J., Kamohara M., Momose K., Tanoue A. Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance. Eur J Pharmacol 2009, 613:182-188.
12. Nonoguchi H., Owada A., Kobayashi N., Takayama M., Terada Y., Koike J., Ujiie K., Marumo F., Sakai T., Tomita K. Immunohistochemical localization of V2 vasopressin receptor along the nephron and functional role of luminal V2 receptor in terminal inner medullary collecting ducts. J Clin Invest 1995, 96:1768-1778.
13. Walsh C.H., Baylis P.H., Malins J.M. Plasma arginine vasopressin in diabetic ketoacidosis. Diabetologia 1979, 16:93-96.
14. Zerbe R.L., Vinicor F., Robertson G.L. Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 1979, 28:503-508.
15. Baylis P.H., Milles J.J., Wilkinson R., Heath D.A. Vasopressin function in hypercalcaemia. Clin Endocrinol (Oxf) 1981, 15:343-351.
16. Milles J.J., Baylis P.H., Wright A.D. Plasma vasopressin during insulin withdrawal in insulin-dependent diabetes. Diabetologia 1981, 20:607-611.
17. Kamoi K., Ishibashi M., Yamaji T. Thirst and plasma levels of vasopressin, angiotensin II and atrial natriuretic peptide in patients with non-insulin-dependent diabetes mellitus. Diab Res Clin Pract 1991, 11:195-202.
18. Rofe A.M., Williamson D.H. Metabolic effects of vasopressin infusion in the starved rat. Reversal of ketonaemia. Biochem J 1983, 212:231-239.
19. Spruce B.A., McCulloch A.J., Burd J., Orskov H., Heaton A., Baylis P.H., Alberti K.G. The effect of vasopressin infusion on glucose metabolism in man. Clin Endocrinol (Oxf) 1985, 22:463-468.
20. Dunning B.E., Moltz J.H., Fawcett C.P. Modulation of insulin and glucagon secretion from the perfused rat pancreas by the neurohypophysial hormones and by desamino-D-arginine vasopressin (DDAVP). Peptides 1984, 5:871-875.
21. Hems D.A. Short-term hormonal control of hepatic carbohydrate and lipid catabolism. FEBS Lett 1977, 80:237-245.
22. Abel'son Iu O. Stimulating effect of arginine vasopressin on the release of free fatty acids by isolated rat adipose cells. Fiziol Zh SSSR Im I M Sechenova 1987, 73:537-540.
23. Despres J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444:881-887.
24. Iwen K.A., Perwitz N., Kraus D., Fasshauer M., Klein J. Putting fat cells onto the road map to novel therapeutic strategies. Discov Med 2006, 6:75-81.
25. van Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J.M., Kemerink G.J., Bouvy N.D., Schrauwen P., Teule G.J. Cold-activated brown adipose tissue in healthy men. N Engl J Med 2009, 360:1500-1508.
26. Cypess A.M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A.B., Kuo F.C., Palmer E.L., Tseng Y.H., Doria A., Kolodny G.M., Kahn C.R. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009, 360:1509-1517.
27. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., Taittonen M., Laine J., Savisto N.J., Enerback S., Nuutila P. Functional brown adipose tissue in healthy adults. N Engl J Med 2009, 360:1518-1525.
28. Klein J., Fasshauer M., Klein H.H., Benito M., Kahn C.R. Novel adipocyte lines from brown fat: a model system for the study of differentiation, energy metabolism, and insulin action. Bioessays 2002, 24:382-388.
29. Klein J., Fasshauer M., Ito M., Lowell B.B., Benito M., Kahn C.R. Beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J Biol Chem 1999, 274:34795-34802.
30. Hiroyama M., Fujiwara Y., Nakamura K., Aoyagi T., Mizutani R., Sanbe A., Tasaki R., Tanoue A. Altered lipid metabolism in vasopressin V1B receptor-deficient mice. Eur J Pharmacol 2009, 602:455-461.
31. Ricquier D. Respiration uncoupling and metabolism in the control of energy expenditure. Proc Nutr Soc 2005, 64:47-52.
32. Erlanson-Albertsson C. The role of uncoupling proteins in the regulation of metabolism. Acta Physiol Scand 2003, 178:405-412.
33. He Y.P., Zhao L.Y., Zheng Q.S., Liu S.W., Zhao X.Y., Lu X.L., Niu X.L., Li X. Involvement of ERK and AKT signaling in the growth effect of arginine vasopressin on adult rat cardiac fibroblast and the modulation by simvastatin. Mol Cell Biochem 2008, 317:33-41.
34. Bastard J.P., Maachi M., Van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., Robert J.J., Capeau J., Hainque B. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002, 87:2084-2089.
35. Lazar M.A. How obesity causes diabetes: not a tall tale. Science 2005, 307:373-375.
36. Mohamed-Ali V., Pinkney J.H., Coppack S.W. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998, 22:1145-1158.
37. Bastard J.P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., Vidal H., Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000, 85:3338-3342.
38. Fernandez-Real J.M., Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003, 24:278-301.
39. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., Ohlsson C., Jansson J.O. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002, 8:75-79.
40. Wallenius K., Wallenius V., Sunter D., Dickson S.L., Jansson J.O. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 2002, 293:560-565.
41. Rasmussen M.S., Lihn A.S., Pedersen S.B., Bruun J.M., Rasmussen M., Richelsen B. Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity (Silver Spring) 2006, 14:28-35.
42. Lihn A.S., Pedersen S.B., Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005, 6:13-21.
43. Yun J.E., Sull J.W., Lee H.Y., Park E., Kim S., Jo J., Lee S.J., Kim S.Y., Choi Y.J., Jee S.H., Huh K.B. Serum adiponectin as a useful marker for metabolic syndrome in type 2 diabetic patients. Diabetes Metab Res Rev 2009, 25:259-265.
44. Wannamethee S.G., Tchernova J., Whincup P., Lowe G.D., Rumley A., Brown K., Cherry L., Sattar N. Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters. Int J Obes (Lond) 2007, 31:1089-1098.
45. Nakashima Y., Inukai K., Imai K., Ikegami Y., Awata T., Katayama S. Involvement of low adiponectin levels in impaired glucose tolerance. Metabolism 2008, 57:1350-1354.
46. Holsboer F., Ising M. Stress hormone regulation: biological role and translation into therapy. Annu Rev Psychol 2010;61:81-109, C1-11.
47. Lolait S.J., Stewart L.Q., Roper J.A., Harrison G., Jessop D.S., Young W.S., O'Carroll A.M. Attenuated stress response to acute lipopolysaccharide challenge and ethanol administration in vasopressin V1b receptor knockout mice. J Neuroendocrinol 2007, 19:543-551.
48. Suzuki H., Kawasaki M., Ohnishi H., Nakamura T., Ueta Y. Regulatory mechanism of the arginine vasopressin-enhanced green fluorescent protein fusion gene expression in acute and chronic stress. Peptides 2009, 30:1763-1770.